OBJECTIVE: To estimate the association of maternal plasma concentrations of tryptophan and six kynurenine pathway metabolites with the risk of preeclampsia. METHODS: The study was based on a subsample of 2,936 pregnant women who delivered singleton neonates in the Norwegian Mother and Child Cohort Study in 2002-2003. Maternal blood plasma was obtained at approximately gestational week 18 and was measured for tryptophan, kynurenine, kynurenic acid, anthranilic acid, 3-hydroxykynurenine, xanthurenic acid, and 3-hydroxyanthranilic acid. RESULTS: Of the 2,936 pregnant women included in this study, 116 (4.0%, 95% confidence interval [CI] 3.2-4.7) had preeclampsia subsequently diagnosed. The prevalence of preeclampsia was significantly higher among women with plasma kynurenic acid concentrations greater than the 95th percentile than among those with concentrations in the 25th-75th percentile (11.0% compared with 3.3%, P<.001; adjusted odds ratio 3.6, 95% CI 1.9-6.8). This association was significantly stronger in women with prepregnancy body mass index of 25 or more (P for interaction=.03; 20.4% compared with 4.2%; P<.001). No statistically significant associations of preeclampsia with other tryptophan metabolites were found. CONCLUSION: Elevated maternal plasma kynurenic acid concentrations in early pregnancy are associated with a substantial increased risk of preeclampsia in obese women. LEVEL OF EVIDENCE: II.
OBJECTIVE: To estimate the association of maternal plasma concentrations of tryptophan and six kynurenine pathway metabolites with the risk of preeclampsia. METHODS: The study was based on a subsample of 2,936 pregnant women who delivered singleton neonates in the Norwegian Mother and Child Cohort Study in 2002-2003. Maternal blood plasma was obtained at approximately gestational week 18 and was measured for tryptophan, kynurenine, kynurenic acid, anthranilic acid, 3-hydroxykynurenine, xanthurenic acid, and 3-hydroxyanthranilic acid. RESULTS: Of the 2,936 pregnant women included in this study, 116 (4.0%, 95% confidence interval [CI] 3.2-4.7) had preeclampsia subsequently diagnosed. The prevalence of preeclampsia was significantly higher among women with plasma kynurenic acid concentrations greater than the 95th percentile than among those with concentrations in the 25th-75th percentile (11.0% compared with 3.3%, P<.001; adjusted odds ratio 3.6, 95% CI 1.9-6.8). This association was significantly stronger in women with prepregnancy body mass index of 25 or more (P for interaction=.03; 20.4% compared with 4.2%; P<.001). No statistically significant associations of preeclampsia with other tryptophan metabolites were found. CONCLUSION: Elevated maternal plasma kynurenic acid concentrations in early pregnancy are associated with a substantial increased risk of preeclampsia in obesewomen. LEVEL OF EVIDENCE: II.
Authors: Katharina Schröcksnadel; Bernhard Widner; Anton Bergant; Gabriele Neurauter; Harald Schennach; Hans Schröcksnadel; Dietmar Fuchs Journal: Life Sci Date: 2003-01-03 Impact factor: 5.037
Authors: Mari Løset; Siv B Mundal; Matthew P Johnson; Mona H Fenstad; Katherine A Freed; Ingrid A Lian; Irina P Eide; Line Bjørge; John Blangero; Eric K Moses; Rigmor Austgulen Journal: Am J Obstet Gynecol Date: 2011-01 Impact factor: 8.661
Authors: Oana M Deac; James L Mills; Barry Shane; Øivind Midttun; Per M Ueland; John T Brosnan; Margaret E Brosnan; Eamon Laird; Eileen R Gibney; Ruzong Fan; Yifan Wang; Lawrence C Brody; Anne M Molloy Journal: J Nutr Date: 2015-02-18 Impact factor: 4.798
Authors: D Theofylaktopoulou; Ø Midttun; A Ulvik; P M Ueland; G S Tell; S E Vollset; O Nygård; S J P M Eussen Journal: Clin Exp Immunol Date: 2013-07 Impact factor: 4.330
Authors: Linde van Lee; Shirong Cai; See Ling Loy; Elaine K H Tham; Fabian K P Yap; Keith M Godfrey; Peter D Gluckman; Lynette P C Shek; Oon Hoe Teoh; Daniel Y T Goh; Kok Hian Tan; Yap Seng Chong; Michael J Meaney; Helen Chen; Birit F P Broekman; Mary F F Chong Journal: J Affect Disord Date: 2017-08-23 Impact factor: 4.839